
INKEF Capital is a venture capital firm that supports early-stage companies, focusing on healthcare and technology sectors. They provide long-term capital and strategic guidance to help startups grow.
INKEF Capital is a leading venture capital firm based in the Netherlands, dedicated to supporting early-stage companies with a focus on the healthcare and technology sectors. Founded in 2010, INKEF offers long-term capital and strategic expertise to help startups scale and succeed. The firm prides itself on building lasting partnerships with entrepreneurs, guiding them from initial investment through to growth and eventual exit. INKEF's investment strategy emphasizes innovation and impact, with a portfolio that includes some of the most promising startups in Europe. By combining financial support with hands-on guidance, INKEF Capital plays a crucial role in the development and success of companies that are driving technological and medical advancements. Their approach is characterized by a deep understanding of the industries they invest in, a commitment to sustainability, and a collaborative spirit that aligns with the long-term goals of their portfolio companies.

Our pitch deck template will guide you through the requirements of an Accelerator-ready presentation.
MrPink VC, based in Punta del Este, Uruguay, enriches the founder experience in South America, focusing on Colombia, Argentina, Peru, Uruguay, and Chile. They invest in unproven entrepreneurs in education, work, food, blockchain, AI, and diversity, offering $50k-$150k seed capital and $200k-$500k for Series A, ensuring swift, founder-friendly investments.
Founded by Skype co-founder Niklas Zennström, Atomico is a high-profile venture capital firm with a strong emphasis on disruptive technologies and global impact. They have a notable presence in London and actively seek out investment opportunities in the city's dynamic startup ecosystem.
SOSV is a global venture capital firm in NYC, Newark, and San Francisco, with $1.5B AUM, focusing on early-stage startups in deep tech, hard tech, and life sciences. They offer pre-seed/seed funding of $250K to $525K and boast a diverse portfolio of 1,000+ companies, supporting human and planetary health, with flagship programs like HAX and IndieBio providing extensive resources.